Medical Cannabis Policy: Thailand’s new enforcement treats cannabis buds as a customs offense, with U.S. travelers warned they could face up to 10 years in prison and steep fines if they import/export or try to bypass rules. Retail Compliance: The UK’s ONCB reiterated that cannabis flower remains prescription-only and warned retailers against sales or advertising that could make products accessible to children. Clinical Research & Safety: A new report links the gut microbiome with the endocannabinoid system, adding fuel to ongoing research into how cannabinoids may interact with health. Medical Devices: A brain implant that detects and stops seizures is being described as life-changing for some epilepsy patients, with early outcomes highlighting improved day-to-day function. Public Health & Impairment: Delaware’s sober-ride program data underscores that impairment isn’t just alcohol—cannabis and other drugs can also affect driving safety. Industry & Markets: Curaleaf’s options trading milestone signals continued momentum in cannabis finance infrastructure. Community Impact: MLB’s Legacy project delivered a major cleanup and makeover for the Shane Victorino Boys & Girls Club in Philadelphia, reinforcing the “safe space” angle that often resonates with medical-hemp audiences.